Clinical trial · Observational
Collection and Distribution of Biospecimens for Novel Research
iSpecimen Network Protocol: Collection and Distribution of Remnant and Research Use Only Biospecimens for Novel Research
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
iSpecimen aims to create a clinical partner network of hospitals, laboratories, academic institutions, and other healthcare organizations ("institutions") capable of providing researchers and educators ("researchers") with annotated biospecimens for use in biomarker discovery and validation; diagnostic test and instrumentation development and validation; therapeutics development; other medical research including the impact that various specimen collection and handling methods and conditions have on research results; and in education such as researcher or physician training (collectively "research").
Conditions
Conditions (8)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Autoimmune Diseases | — | UNRESOLVED | — |
| Blood Disease | — | UNRESOLVED | — |
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Dermatologic Disease | — | UNRESOLVED | — |
| Gastrointestinal Complication | — | UNRESOLVED | — |
| Healthy | — | UNRESOLVED | — |
| Infectious Disease | — | UNRESOLVED | — |
| Women's Health: High-Risk Pregnancy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Observational | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Collection of Biospecimens for Novel Research Uses
- timeFrame
- 10 years
- description
- Repository of diseased and healthy tissue, blood derivatives and related biological specimens
Secondary outcomes (1)
- measure
- Number of subjects enrolled
- timeFrame
- 10 years
- description
- Each subject will have contributed at least one biospecimen
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 1 Year
- Maximum age
- 99 Years
Show eligibility criteria text
Inclusion Criteria: * Individual is developmentally aged 7 years old and above for RUO collections (only) * Individual meets requirements of a current request for research materials from iSpecimen * If a blood collection will be performed as part of the screening process or RUO collection, the individual's health will be assessed by medical staff through medical record review, clinical exam, and/or the review of an updated medical history as provided by the participant * Individual has reviewed and signed a consent form for an RUO specimen collection if required as part of the research or if a minor or a person with diminished decision-making capacity, their parent/guardian or Legally Authorized - Representative has reviewed and signed the consent form on their behalf. * Individual has reviewed and signed a consent form for remnant specimen usage in research if required as part of the research or if a minor or a person with diminished decision-making capacity, their parent/guardian or Legally Authorized Representative has reviewed and signed the consent form on their behalf Exclusion Criteria: \- Subjects that do not meet the inclusion criteria outlined above.
References
Publications (0)
Data not yet available